Natco Pharma Ltd.
| BSE: 524816 | Sector: Health care |
| NSE: NATCOPHARM | ISIN Code: INE987B01026 |
| BSE 00:00 | 24 Apr | Natco Pharma Ltd is not traded on BSE in the last 30 days |
| NSE 05:30 | 01 Jan | Natco Pharma Ltd is not traded on NSE in the last 30 days |
| OPEN | 612.00 |
| PREVIOUS CLOSE | 617.20 |
| VOLUME | 24402 |
| 52-Week high | 737.80 |
| 52-Week low | 450.00 |
| P/E | 22.88 |
| Mkt Cap.(Rs cr) | 11,366 |
| Buy Price | 624.35 |
| Buy Qty | 54.00 |
| Sell Price | 628.95 |
| Sell Qty | 2.00 |
About Natco Pharma Ltd.
Natco Pharma Ltd
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company's focus is primarily on niche therapeutic areas and complex products. The company sells its products in over 40 countries. FDF products are sold in the United States I...> More
Natco Pharma Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr)
|
11,366 | |
| EPS - TTM | () |
[*S] | 27.29 |
| P/E Ratio | (X) | [*S] | 22.88 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 175.00 | |
| Latest Dividend Date | 24 Feb 2020 | ||
| Dividend Yield | (%) | 1.01 | |
| Book Value / Share | () |
[*S] | 206.52 |
| P/B Ratio | () |
[*S] | 3.02 |
Natco Pharma Ltd - Financial Results
Particulars ( cr) |
Dec 2019 | Dec 2018 | % Chg |
| Net Sales | 482.2 | 556.7 | -13.38 |
| Other Income | 30.8 | 23.3 | 32.19 |
| Total Income | 513 | 580 | -11.55 |
| Total Expenses | 353.5 | 348.3 | 1.49 |
| Operating Profit | 159.5 | 231.7 | -31.16 |
| Net Profit | 104.4 | 159.3 | -34.46 |
| Equity Capital | 36.4 | 36.8 | - |
Natco Pharma Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Alembic Pharma | 759.35 | 8.70 | 14313.75 |
| Ajanta Pharma | 1444.55 | 8.77 | 12603.70 |
| Syngene Intl. | 306.70 | -2.12 | 12268.00 |
| Natco Pharma | 624.35 | 1.16 | 11366.29 |
| Glenmark Pharma. | 345.05 | 1.44 | 9737.31 |
| Astrazeneca Phar | 2777.50 | 7.33 | 6943.75 |
| Proc. Gam. Heal. | 4159.20 | -0.05 | 6904.27 |
Natco Pharma Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherNatco Pharma Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | 1.30% | 1.43% | -0.83% | -1.21% |
| 1 Month | 32.63% | 32.58% | 17.44% | 17.35% |
| 3 Month | -5.42% | -5.35% | -24.72% | -25.26% |
| 6 Month | 6.91% | 6.88% | -19.72% | -20.96% |
| 1 Year | 15.59% | 15.71% | -19.79% | -21.93% |
| 3 Year | -32.64% | -32.48% | 5.64% | -0.69% |
Natco Pharma Ltd - STOCK STRENGTH
| Today's Low/High | 609.15 |
|
642.00 |
| Week Low/High | 596.95 |
|
643.00 |
| Month Low/High | 450.00 |
|
650.00 |
| YEAR Low/High | 450.00 |
|
738.00 |
| All TIME Low/High | 1.60 |
|
1080.00 |
Quick Links for Natco Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
